Stifel Reiterates Buy Rating on Celldex Therapeutics (CLDX)
Go back to Stifel Reiterates Buy Rating on Celldex Therapeutics (CLDX)| CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) | Delayed: 41.83 -0.78 (1.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.61 | 52 Week High | $18.62 | |||
| Open | $42.23 | 52 Week Low | $2.85 | |||
| Day High | $42.35 | P/E | N/A | |||
| Day Low | $40.88 | EPS | $-1.02 | |||
| Volume | 610,496 | |||||
